Using manually selected ROI in xenografted human breast tumours, reduced vascular permeability has been seen to a similar extent in both the tumour rim and its centre, following administration of an anti-VEGF antibody (Pham et al., 1998). This evidence concerns the gene VEGFA and breast neoplasm.